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1. Introduction
  Pandemic H1N1/09 influenza virus infection has been 
identified as the cause of a wide spread outbreak of febrile 
respiratory infection worldwide[1]. Pandemic H1N1/09 
infection also swept throughout India[2]. In the wake of the 
pandemic, a newborn infected with novel H1N1/09 influenza 
virus admitted to a teaching hospital in Kolkata, India who 
acquired infection through person to person contacts or 
by respiratory droplets. Spread of this infection through 
these routes is very common in older children and adults[1] 
however; it was not yet reported in newborns. In contrast, 
vertical transmission of H1N1/09 infection from pregnant 
women to the newborns has been published during the 
pandemic period[3-5]. 
2. Case report
  A male infant was born to a 21 year-old- mother at 36 
weeks gestation and weighed 2 200 g by normal vaginal 
delivery at hospital set up on 9th July, 2010. Apgar scores 
were 9 both at 1 and 5 min. The mother did not have 
significant past medical history of respiratory infection 
for last one month. She did not recall any contacts with ill 
individuals and denied recent travel. Mother and baby were 
discharged from hospital on next day of delivery. Baby was 
looked after by his mother and was exclusive breast fed up 
to day 4. However, mother developed severe dehydrating 
diarrhea and admitted to another hospital on day 5. Baby 
was at home and developed fever, occasional cough and 
vomiting on that day. Baby became lethargic and developed 
respiratory distress on day 6 for which he was admitted to 
the hospital on day 7. 
  On physical examination, the baby was weighed 1 800 g and 
had high grade of fever (39 曟) with respiratory distress. 
Respiratory rate was 66/min and respiration was mainly 
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abdominal. Silverman scoring for gradation of respiratory 
distress was 3. Few crepts were detected on auscultation 
in both the lungs. Chest radiograph revealed hyper 
inflated lungs. Hematological examinations showed the 
following: hemoglobin 12.1 g/dL, total leucocytes-26 800/
mm3, differential count (cells/µL of blood): lymphocytes 7 236, 
neutrophil 18 760, eosinophil 536, monocytes 268, platelet 
count 101 000 mm3. Estimation (mg/dL) of conjugated, un-
conjugated bilirubin and C-reactive protein showed 16, 4 
and 24 respectively. Other systems were within normal limit. 
  As the baby was admitted during the epidemic period, 
nasopharyngeal swab specimens collected on day 7 and 8 
were examined for pandemic H1N1/09 using the standard 
CDC methodology[6]. Extraction of viral RNA from the clinical 
samples was carried out using commercially available 
QiaAmp Viral RNA Mini Kit (Qiagen, GmbH, Hilden, 
Germany) according to the manufacturer’s instruction. One-
step Real-time RT-PCR assay was performed using TaqMan 
Influenza Assay Kit (Part No. 4401512, Applied Biosystems, 
Foster City, USA) and AgPath-ID One-Step RT-PCR Kit (Part 
No.4387391, Ambion, Austin, USA) for diagnosis of pandemic 
H1N1. Each sample was subjected to four reactions 
testing for influenza A matrix (M) gene, pandemic H1N1 
nucleoprotein (NP), pandemic H1N1 hemagglutinin (HA1) 
gene and human gene RNase P as an internal control[6]. 
After receiving positive result of H1N1/09 of the baby, 
nasopharyngeal swabs of both the parents and grandparents 
were also examined which were negative for H1N1/09. 
  The baby was put on intravenous antibiotics (cefotaxim and 
amikacin) empirically. Fluid and electrolyte balance was 
maintained intravenously and subsequently by nesogastic 
feeding till the baby became breast fed. Baby was on 
supportive therapy with moist oxygen supplementation and 
paracetamol. However, temperature continued till day 14 
but repeat examination of nasopharyngeal swab showed 
elimination of pandemic H1N1/09. Due to continued fever, 
blood sample was collected aseptically to detect bacterial 
pathogen on day 15 using standard technique. Klebsiella 
pneumoniae (K. pneumoniae) was grown in blood culture 
after 24 h of incubation. The antimicrobial susceptibility 
of this isolate was determined by Kirby Bauer’s disc 
diffusion method using a panel of commercially available 
discs (Beckton Dickenson, MD, USA). Minimum Inhibitory 
Concentrations (MICs) of the antibiotics for this isolate were 
determined by E-test strips (AB BIODISK, Solna, Sweden) 
according to manufacturer’s recommendations. E. coli ATCC 
25922 was used as a reference strain for quality control 
checking. Results were interpreted as per Clinical Laboratory 
Standard Institute guidelines[7]. The isolate was susceptible 
to chloramphenicol, tetracycline, amikacin, nalidixic 
acid, norfloxacin, ciprofloxacin, ofloxacin, levofloxacin, 
gatifloxacin, imipenem and meropenem but resistant to the 
following antimicrobials with their MICs: ampicillin (>256 毺
L/mL), piperacillin (>256 毺L/mL), co-trimoxazole (>32 毺
L/mL), cefotaxime (>256 毺L/mL), ceftazidime (>256 毺
L/mL), ceftriaxone (>256 毺L/mL), cefpodoxime (>256 毺
L/mL), cefipime (>256 毺L/mL), cefixime (>256 毺L/mL), 
azithromycin (>256 毺L/mL), aztreonam (>256 毺L/mL). The 
isolate was shown to be positive for Extended Spectrum of 
Beta Lactamase (ESBL) by phenotypic test. 
  We changed the antibiotics to meropenum (60 mg/kg/d in three 
divided doses) on day 18 as the isolates of K. pneumonia 
was susceptible to that drug and continued for 12 d. No 
antiviral drug was given. On day 23, baby became afebrile 
and respiratory distress subsided without any complication. 
Baby was stable, had breast milk and gained weight during 
hospital stay. Baby was discharged from the hospital on day 
30. The baby was also doing well during subsequent follow 
up visit at the age of two months.
3. Discussion
  Failure of detection of H1N1/09 infection in neonates 
during the epidemic period in Hong Kong[8], indicated that it 
is still a myth that neonates have some specific mechanism 
that brings resistant to this respiratory infection[9]. However 
experts opined that there are many more cases of neonatal 
H1N1/09 infection elsewhere in the world[10], but there is 
no published document of horizontal transmission of H1N1 
infection in neonates till date. To our knowledge, this is the 
first case report of seven days old newborn who acquired 
H1N1/09 infection horizontally through person to person 
close contacts or by respiratory droplets though this route 
of transmission is very common among older children and 
adults[1]. Earlier reports documented vertical transmission 
of H1N1/09 infection from their mothers[3-5] though 
transmission by this route was thought to be rare[11]. 
  Baby was well till day 6 of birth and the prenatal and 
immediate postnatal periods of his mother were uneventful 
indicated that he did not acquired infection vertically. 
However, mother developed severe dehydrating diarrhea in 
later half of postnatal period but her nasopharyngeal swab 
was negative for H1N1/09 which negated the possibility 
of H1N1/09 related diarrhea in mother and possibility of 
transmission of infection to the baby. During pandemic, 
a good proportion of pediatric inpatients were positive for 
H1N1/09 in USA but none was in neonatal age group[12]. 
Neonates suffering from respiratory infection were screened 
for H1N1/09 infection during the epidemic period in Hong 
Kong which showed that H1N1/09 did not appear to be the 
prevalent respiratory virus in neonates[8]. 
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  Probably the baby acquired the infection through person 
to person close contacts or by respiratory droplets at home 
from other asymptomatic family members except parents 
and grandparents as they were negative for H1N1/09. To 
avoid transmission, direct caregivers along with other family 
members and visitors should also pay special attention 
to personal and hand hygiene whenever they are in close 
contact of the newborns. 
  Possibility of transmission of this infection from the 
hospital staff during delivery or during post delivery care 
cannot be ignored as seropositivity of H1N1/09 among 
hospital staff was high in different countries including 
India[13]. Hospital staffs should receive health education 
regarding infection control practices due to presence of high 
percentage of asymptomatic subjects in the community and 
they became the potential source of infection[2,13]. Health 
authority should take appropriate preventive measures to 
minimize the spread of infection. 
  We initiated treatment of this febrile newborn with 
cefotaxim and amikacin empirically but the baby had 
continued fever till day 17 even after elimination of 
H1N1/09. Bacteriological report of blood culture showed 
presence of multidrug resistant K. pneumonia which 
explained no response of initial combined therapy however 
baby responded with meropenem as the stain was highly 
susceptible to that drug. World Health Organization (WHO) 
also recommended use of antibiotic empirically as H1N1/09 
infections are usually associated with bacterial co-infection 
in children including neonates in developing countries[14]. 
Antibiotic therapy became an integrated part of treatment 
of H1N1 to combat bacterial co-infection in newborns in 
developing countries like ours[14].
  We did not use any antiviral agent to this newborn as 
routine antiviral therapy was not recommended by WHO 
to all H1N1/09 infected patients[14]. Furthermore, the use of 
antiviral agents in newborns is problematic and not regarded 
as safe[8]. Elimination of this infection without antiviral 
therapy indicated that antiviral agent may not be required 
for all H1N1/09 infected cases. 
  In conclusion, it is fact that newborn can be infected 
with H1N1/09 virus and the transmission can be occurred 
horizontally even by asymptomatic contacts. Special 
attention to personal as well as hand hygiene among the 
close contacts of newborns is the main public health 
importance to avoid the transmission of this infection.
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